• Mashup Score: 8

    The JHLT Digital Media Editors explore two manuscripts from the October issue of The Journal of Heart and Lung Transplantation—the first on lung transplantation in patients with stacked risks, and the second on bacterial pathogens found at driveline exit sites in patients with ventricular assist devices. Digital Media Editor Marty Tam, MD, assistant professor in the division of cardiovascular medicine at the University of Michigan, hosts this episode.   First, hear from senior author Edward Cantu, MD, MSCE, on his team’s study “.”   Lung transplant centers are increasingly evaluating patients with multiple risk factors for adverse post-transplant outcomes, yet there is little data of the effects of these risks as they stack. The authors of the study used the UNOS registry data linked to the National Inpatient Sample (NIS) to create a national encounter-level sample of healthcare data in the United States, then applied a probabilistic matching algorithm using 7 variables and determined

    Tweet Tweets with this article
    • RT @TheJHLT: 🚨October #JHLTThePodcast! đź”—https://t.co/vW3QyOtRit We talk with @_EdCantu_ @PennMedicine on stacked risks in #LungTx candidate…

    • RT @TheJHLT: 🚨October #JHLTThePodcast! đź”—https://t.co/vW3QyOtRit We talk with @_EdCantu_ @PennMedicine on stacked risks in #LungTx candidate…

    • 🚨October #JHLTThePodcast! đź”—https://t.co/vW3QyOtRit We talk with @_EdCantu_ @PennMedicine on stacked risks in #LungTx candidates, and discuss bacterial pathogens in driveline infections in #VAD patients from University Hospital, Bern. https://t.co/xn2ccyc5qt

  • Mashup Score: 0

    In this special issue of JHLT: The Podcast, the JHLT Digital Media Editors explore just one study—and devote the second half of the episode as a tribute to recently retired Editor-in-Chief, Dr. Daniel R. Goldstein. Digital Media Editor Van-Khue Ton, MD, heart failure and transplant cardiologist at Massachusetts General Hospital, hosts this episode.   First, hear from senior author William F. Parker, MD, MS, PhD, on his team’s study “.” Dr. Parker is a pulmonary and critical care physician, health services researcher, and clinical medical ethicist, and he runs a R01 funded lab focusing on the allocation of scarce healthcare resources.   In the study, Dr. Parker and colleagues set out to examine the Scientific Registry of Transplant Recipients (SRTR) to compare medical urgency of heart transplant patients listed with exception vs. those listed according to standard guidelines. The study’s main finding: after controlling for status as a time-varying covariate, candidates with an exception

    Tweet Tweets with this article
    • 🎧 Don't forget to listen to the September #JHLTThePodcast! đź”— https://t.co/Dq63SudIgT and your favorite podcatcher. This episode includes a tribute to recently retired Editor-in-Chief Dr. Daniel R. Goldstein and a dicussion on waitlist mortality among #HeartTx candidates. https://t.co/rX08SqPGiT

  • Mashup Score: 0

    In this special issue of JHLT: The Podcast, the JHLT Digital Media Editors explore just one study—and devote the second half of the episode as a tribute to recently retired Editor-in-Chief, Dr. Daniel R. Goldstein. Digital Media Editor Van-Khue Ton, MD, heart failure and transplant cardiologist at Massachusetts General Hospital, hosts this episode.   First, hear from senior author William F. Parker, MD, MS, PhD, on his team’s study “.” Dr. Parker is a pulmonary and critical care physician, health services researcher, and clinical medical ethicist, and he runs a R01 funded lab focusing on the allocation of scarce healthcare resources.   In the study, Dr. Parker and colleagues set out to examine the Scientific Registry of Transplant Recipients (SRTR) to compare medical urgency of heart transplant patients listed with exception vs. those listed according to standard guidelines. The study’s main finding: after controlling for status as a time-varying covariate, candidates with an exception

    Tweet Tweets with this article
    • Listen to the September #JHLTThePodcast for a special tribute to Daniel R. Goldstein and a discussion on waitlist mortality among #HeartTx candidates with @WF_Parker. Check the 🧵thread below for details on the studies, and listen at https://t.co/0VcATg5wDm https://t.co/lSR3D4v9Uo

  • Mashup Score: 8

    In this special issue of JHLT: The Podcast, the JHLT Digital Media Editors explore just one study—and devote the second half of the episode as a tribute to recently retired Editor-in-Chief, Dr. Daniel R. Goldstein. Digital Media Editor Van-Khue Ton, MD, heart failure and transplant cardiologist at Massachusetts General Hospital, hosts this episode.   First, hear from senior author William F. Parker, MD, MS, PhD, on his team’s study “.” Dr. Parker is a pulmonary and critical care physician, health services researcher, and clinical medical ethicist, and he runs a R01 funded lab focusing on the allocation of scarce healthcare resources.   In the study, Dr. Parker and colleagues set out to examine the Scientific Registry of Transplant Recipients (SRTR) to compare medical urgency of heart transplant patients listed with exception vs. those listed according to standard guidelines. The study’s main finding: after controlling for status as a time-varying covariate, candidates with an exception

    Tweet Tweets with this article
    • RT @TheJHLT: 🎧 September #JHLTThePodcast is out! đź”— https://t.co/0VcATg4YNO and your favorite podcatcher. This episode includes a tribute to…

    • September #JHLTThePodcast also features @WF_Parker on his team's study "Association of high-priority exceptions with #waitlist mortality among #HeartTx candidates," published in this month's issue of #JHLT. đź”— https://t.co/0VcATg4YNO and your favorite podcatcher.

    • 🎧 September #JHLTThePodcast is out! đź”— https://t.co/0VcATg4YNO and your favorite podcatcher. This episode includes a tribute to recently retired Editor-in-Chief Dr. Daniel R. Goldstein, with heartfelt comments from @MKIttlesonMD, Andrew Gelman, Andy Fisher, @dantyrr & Judy Chen. https://t.co/KBFdvncdXm

  • Mashup Score: 1

    The JHLT Digital Media Editors explore two manuscripts from the August issue of The Journal of Heart and Lung Transplantation—the first on immunosuppression in pediatric heart transplantation, and the second TA-NRP in DCD lung transplantation. Digital Media Editor Van-Khue Ton, MD, heart failure and transplant cardiologist at Massachusetts General Hospital, hosts this episode.   First, hear from senior author Steven C. Greenway, MSc, MD, on his team’s study “.” Dr. Greenway shares his journey from enzyme biochemistry in mollusks, snails, and frogs to pediatric cardiology, then outlines the results of the paper.   The study queried the Pediatric Heart Transplant Society’s registry to determine the efficacy and safety of monotherapy immunosuppression. The results showed better graft survival and less coronary allograft vasculopathy in the monotherapy group, even after adjusted for age at transplant, sex, neonatal transplant, infection, PTLD, and etiology of cardiomyopathy. Dr. Greenway a

    Tweet Tweets with this article
    • Listen to the August #JHLTThePodcast for great discussions on #immunosuppression in peds #HeartTx and TA-NRP on early outcomes in #DCD #LungTx from Steven C. Greenway and @JadMalasMD. Check the 🧵thread below for details on the studies, and listen at https://t.co/pVodmrbHMV https://t.co/N7EiMw2ZzB

  • Mashup Score: 0

    The JHLT Digital Media Editors explore two manuscripts from the August issue of The Journal of Heart and Lung Transplantation—the first on immunosuppression in pediatric heart transplantation, and the second TA-NRP in DCD lung transplantation. Digital Media Editor Van-Khue Ton, MD, heart failure and transplant cardiologist at Massachusetts General Hospital, hosts this episode.   First, hear from senior author Steven C. Greenway, MSc, MD, on his team’s study “.” Dr. Greenway shares his journey from enzyme biochemistry in mollusks, snails, and frogs to pediatric cardiology, then outlines the results of the paper.   The study queried the Pediatric Heart Transplant Society’s registry to determine the efficacy and safety of monotherapy immunosuppression. The results showed better graft survival and less coronary allograft vasculopathy in the monotherapy group, even after adjusted for age at transplant, sex, neonatal transplant, infection, PTLD, and etiology of cardiomyopathy. Dr. Greenway a

    Tweet Tweets with this article
    • Have you listened to the August #JHLTThePodcast yet? Great stuff on #immunosuppression in peds #HeartTx and TA-NRP on early outcomes in #DCD #LungTx from Steven C. Greenway and @JadMalasMD! Check the thread🧵below for details on the studies, and listen at https://t.co/pVodmrbHMV https://t.co/N7EiMw2ZzB

  • Mashup Score: 2

    The JHLT Digital Media Editors explore two manuscripts from the August issue of The Journal of Heart and Lung Transplantation—the first on immunosuppression in pediatric heart transplantation, and the second TA-NRP in DCD lung transplantation. Digital Media Editor Van-Khue Ton, MD, heart failure and transplant cardiologist at Massachusetts General Hospital, hosts this episode.   First, hear from senior author Steven C. Greenway, MSc, MD, on his team’s study “.” Dr. Greenway shares his journey from enzyme biochemistry in mollusks, snails, and frogs to pediatric cardiology, then outlines the results of the paper.   The study queried the Pediatric Heart Transplant Society’s registry to determine the efficacy and safety of monotherapy immunosuppression. The results showed better graft survival and less coronary allograft vasculopathy in the monotherapy group, even after adjusted for age at transplant, sex, neonatal transplant, infection, PTLD, and etiology of cardiomyopathy. Dr. Greenway a

    Tweet Tweets with this article
    • RT @TheJHLT: ▶️August #JHLTThePodcast is out now! It's at https://t.co/pVodmrbHMV and on your favorite podcatcher. We've added a 🧵👇 thread…

  • Mashup Score: 3

    The JHLT Digital Media Editors explore two manuscripts from the August issue of The Journal of Heart and Lung Transplantation—the first on immunosuppression in pediatric heart transplantation, and the second TA-NRP in DCD lung transplantation. Digital Media Editor Van-Khue Ton, MD, heart failure and transplant cardiologist at Massachusetts General Hospital, hosts this episode.   First, hear from senior author Steven C. Greenway, MSc, MD, on his team’s study “.” Dr. Greenway shares his journey from enzyme biochemistry in mollusks, snails, and frogs to pediatric cardiology, then outlines the results of the paper.   The study queried the Pediatric Heart Transplant Society’s registry to determine the efficacy and safety of monotherapy immunosuppression. The results showed better graft survival and less coronary allograft vasculopathy in the monotherapy group, even after adjusted for age at transplant, sex, neonatal transplant, infection, PTLD, and etiology of cardiomyopathy. Dr. Greenway a

    Tweet Tweets with this article
    • ▶️August #JHLTThePodcast is out now! It's at https://t.co/pVodmrbHMV and on your favorite podcatcher. We've added a 🧵👇 thread below for details on the studies covered. @malas_jad @MartyTamMD @tonkhueMdPhd @DSchibilsky @MKIttlesonMD https://t.co/byA7DXjKc5

  • Mashup Score: 2

    The JHLT Digital Media Editors explore two manuscripts from the July issue of The Journal of Heart and Lung Transplantation—one on heart transplantation and one on lung transplantation. Digital Media Editor Marty C. Tam, MD, Assistant Professor at the University of Michigan, hosts this episode.   First, hear from co-first author Kevin Chen, MD, on his team’s study “,” which comes from Cedars-Sinai. The study looks into the results of DCD organ donation depending on the technique used at procurement, mainly comparing ex-situ normothermic organ perfusion with thoracoabdominal normothermic regional perfusion (TA-NRP).   Digital Media Editors David Schibilsky, MD, and Van-Khue Ton, MD, have questions on the relationship between DCD liver and kidney procurement and heart procurement strategies, why TA-NRP livers and kidneys might differ, and the lower incidence of delayed graft function in DCD kidney transplants with TA-NRP. Dr. Chen also shares some thoughts about how this work might be in

    Tweet Tweets with this article
    • Have you listened to the July #JHLTThePodcast yet? Some good stuff on #DCD hearts and #LungTx #frailty from @KevinQ_Chen and @jsinger0 this month! Check the thread🧵below for details on the studies, and listen on your favorite podcatcher (or at https://t.co/tTZx5okVHL). https://t.co/S72duOMF0F